Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:107-116
Published online before print June 12, 2008, doi: 10.1161/CIRCRESAHA.108.178525
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/1/107    most recent
CIRCRESAHA.108.178525v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rota, M.
Right arrow Articles by Kajstura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rota, M.
Right arrow Articles by Kajstura, J.
Related Collections
Right arrow Remodeling
Right arrow Growth factors/cytokines
Right arrow Heart failure - basic studies
Right arrow Myogenesis
Right arrow Chronic ischemic heart disease
(Circulation Research. 2008;103:107.)
© 2008 American Heart Association, Inc.


Integrative Physiology

Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function

Marcello Rota, M. Elena Padin-Iruegas, Yu Misao, Antonella De Angelis, Silvia Maestroni, João Ferreira-Martins, Emanuela Fiumana, Raffaella Rastaldo, Michael L. Arcarese, Thomas S. Mitchell, Alessandro Boni, Roberto Bolli, Konrad Urbanek, Toru Hosoda, Piero Anversa, Annarosa Leri, Jan Kajstura

From the Departments of Anesthesia and Medicine and Division of Cardiology (M.R., M.E.P.-I., Y.M., A.D.A., S.M., J.F.-M., E.F., R.R., M.L.A., T.S.M., A.B., K.U., T.H., P.A., A.L., J.K.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and Institute of Molecular Cardiology (R.B.), University of Louisville, Ky.

Correspondence to Marcello Rota, PhD, Departments of Anesthesia and Medicine and Division of Cardiology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA 02115. E-mail mrota{at}zeus.bwh.harvard.edu

Ischemic heart disease is characterized chronically by a healed infarct, foci of myocardial scarring, cavitary dilation, and impaired ventricular performance. These alterations can only be reversed by replacement of scarred tissue with functionally competent myocardium. We tested whether cardiac progenitor cells (CPCs) implanted in proximity of healed infarcts or resident CPCs stimulated locally by hepatocyte growth factor and insulin-like growth factor-1 invade the scarred myocardium and generate myocytes and coronary vessels improving the hemodynamics of the infarcted heart. Hepatocyte growth factor is a powerful chemoattractant of CPCs, and insulin-like growth factor-1 promotes their proliferation and survival. Injection of CPCs or growth factors led to the replacement of {approx}42% of the scar with newly formed myocardium, attenuated ventricular dilation and prevented the chronic decline in function of the infarcted heart. Cardiac repair was mediated by the ability of CPCs to synthesize matrix metalloproteinases that degraded collagen proteins, forming tunnels within the fibrotic tissue during their migration across the scarred myocardium. New myocytes had a 2n karyotype and possessed 2 sex chromosomes, excluding cell fusion. Clinically, CPCs represent an ideal candidate cell for cardiac repair in patients with chronic heart failure. CPCs may be isolated from myocardial biopsies and, following their expansion in vitro, administered back to the same patients avoiding the adverse effects associated with the use of nonautologous cells. Alternatively, growth factors may be delivered locally to stimulate resident CPCs and promote myocardial regeneration. These forms of treatments could be repeated over time to reduce progressively tissue scarring and expand the working myocardium.


Key Words: cardiac repair • cardiac stem cells • chronic myocardial infarct




This article has been cited by other articles:


Home page
CirculationHome page
K. M. Fischer, C. T. Cottage, W. Wu, S. Din, N. A. Gude, D. Avitabile, P. Quijada, B. L. Collins, J. Fransioli, and M. A. Sussman
Enhancement of Myocardial Regeneration Through Genetic Engineering of Cardiac Progenitor Cells Expressing Pim-1 Kinase
Circulation, November 24, 2009; 120(21): 2077 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. A. D'Alessandro, J. Kajstura, T. Hosoda, A. Gatti, R. Bello, F. Mosna, S. Bardelli, H. Zheng, D. D'Amario, M. E. Padin-Iruegas, et al.
Progenitor Cells From the Explanted Heart Generate Immunocompatible Myocardium Within the Transplanted Donor Heart
Circ. Res., November 20, 2009; 105(11): 1128 - 1140.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Ferreira-Martins, C. Rondon-Clavo, D. Tugal, J. A. Korn, R. Rizzi, M. E. Padin-Iruegas, S. Ottolenghi, A. De Angelis, K. Urbanek, N. Ide-Iwata, et al.
Spontaneous Calcium Oscillations Regulate Human Cardiac Progenitor Cell Growth
Circ. Res., October 9, 2009; 105(8): 764 - 774.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Wang, M. N. Jameel, Q. Li, A. Mansoor, X. Qiang, C. Swingen, C. Panetta, and J. Zhang
Stem Cells for Myocardial Repair With Use of a Transarterial Catheter
Circulation, September 15, 2009; 120(11_suppl_1): S238 - S246.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Padin-Iruegas, Y. Misao, M. E. Davis, V. F.M. Segers, G. Esposito, T. Tokunou, K. Urbanek, T. Hosoda, M. Rota, P. Anversa, et al.
Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction
Circulation, September 8, 2009; 120(10): 876 - 887.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. C. Quevedo, K. E. Hatzistergos, B. N. Oskouei, G. S. Feigenbaum, J. E. Rodriguez, D. Valdes, P. M. Pattany, J. P. Zambrano, Q. Hu, I. McNiece, et al.
Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity
PNAS, August 18, 2009; 106(33): 14022 - 14027.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
K. D. Boudoulas and A. K. Hatzopoulos
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease
Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Patane and F. Marte
Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system
Eur. Heart J., May 2, 2009; 30(10): 1169 - 1170.
[Abstract] [Full Text] [PDF]